Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
Population Health Research Institute · Hamilton Health Sciences · +26 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
754
total citations
- FWCI
- 72.76
- Percentile
- 100%
- References
- 49
Citations per year
Authors
642- SJStuart J. ConnollyCorresponding
Population Health Research Institute, Hamilton Health Sciences, McMaster University
- JWJohn W. Eikelboom
Population Health Research Institute, Hamilton Health Sciences, McMaster University
- JBJackie Bosch
McMaster University
- GRGilles R. Dagenais
Institut universitaire de cardiologie et de pneumologie de Québec
- LDLeanne Dyal
Population Health Research Institute, Hamilton Health Sciences, McMaster University
Topics & keywords
Topics
Keywords
- Rivaroxaban
- Medicine
- Aspirin
- Placebo
- Coronary artery disease
- Cardiology
- Internal medicine
- Double blind
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.